101 studies found for:    Open Studies | "Amyotrophic Lateral Sclerosis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Amyotrophic Lateral Sclerosis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting The National Amyotrophic Lateral Sclerosis Registry
Condition: Amyotrophic Lateral Sclerosis
Intervention:
2 Unknown  Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis;   Chronic Respiratory Failure
Interventions: Device: Non invasive ventilation delivered with one of the ventilator specifically designed for NIV and given to the patient by the home care providers;   Device: Non invasive ventilation
3 Recruiting Aerobic Exercise Training in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Aerobic exercise training;   Other: Standard physical therapy (Stretching/Range-of-motion)
4 Recruiting Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: MRI + 18FDG-PET + neuropsychological assessments ; 18FDG performed especially for the research
5 Recruiting Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Device: Faros Sensor (FS) and LifeInsight Hub;   Device: Fast Fix electrode patch;   Procedure: Quantitative Measure of Speech (Core Phase Only)
6 Not yet recruiting HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: Raltegravir;   Drug: Zidovudine
7 Unknown  Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Cistanche Total Glycosides
8 Recruiting Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS Mode
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: Non-invasive home ventilation
9 Recruiting Identification of Diagnostic And Prognostic Biomarkers From Amyotrophic Lateral Sclerosis (ALS) Skin and Adipose Samples
Condition: Amyotrophic Lateral Sclerosis
Intervention:
10 Recruiting Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo (for MN-166);   Drug: MN-166
11 Unknown  Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis;   Motor Neuron Disease;   Neuromuscular Disease;   Neurodegenerative Disease;   Central Nervous System Disease
Intervention: Genetic: HYNR-CS-Allo
12 Recruiting Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
Condition: ALS (Amyotrophic Lateral Sclerosis)
Intervention: Other: Diaphragmatic endurance test
13 Recruiting Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis
Condition: Motor Neuron Disease/Amyotrophic Lateral Sclerosis
Intervention: Biological: Stem Cell
14 Unknown  Cortex Changes in Real/Imagined Movements in Amyotrophic Lateral Sclerosis (ALS)
Conditions: ALS;   Amyotrophic Lateral Sclerosis
Intervention:
15 Recruiting The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study
Condition: Amyotrophic Lateral Sclerosis
Intervention:
16 Not yet recruiting Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: mesenchymal stem cell
17 Not yet recruiting Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo;   Drug: 1.0 MIU IL-2 per day;   Drug: 2.0 MIU IL-2 per day
18 Recruiting Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Resistance Exercise;   Other: Endurance Exercise;   Other: Stretching/Range-of-Motion
19 Recruiting Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: Rasagiline;   Drug: Placebo
20 Recruiting Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Amyotrophic Lateral Sclerosis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years